Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
Thomas Wiesner, Ping Chi(Memorial Sloan Kettering Cancer Center), Charlotte E. Ariyan(Memorial Sloan Kettering Cancer Center), Shipra Shukla(Memorial Sloan Kettering Cancer Center), Gary K. Schwartz(Cornell University), Michael A. Postow(Memorial Sloan Kettering Cancer Center), Zhen Cao(Memorial Sloan Kettering Cancer Center), Iñigo Landa(Brigham and Women's Hospital), Julia Button(Memorial Sloan Kettering Cancer Center), Klaus J. Busam(Memorial Sloan Kettering Cancer Center), Wenhuo Hu(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Dong Gao(Chinese Academy of Sciences), Nathalie Lailler(Memorial Sloan Kettering Cancer Center), Sasinya N. Scott(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Andrea Sboner(NewYork–Presbyterian Hospital), Ronak Shah(Memorial Sloan Kettering Cancer Center), Travis J. Hollmann, Deyou Zheng(Albert Einstein College of Medicine), Rajmohan Murali(Memorial Sloan Kettering Cancer Center), Qi Fan Zhang(Memorial Sloan Kettering Cancer Center), Elissa W.P. Wong(Memorial Sloan Kettering Cancer Center), Laetitia Borsu(Memorial Sloan Kettering Cancer Center), Anna C. Obenauf(Research Institute of Molecular Pathology), James A. Fagin(Memorial Sloan Kettering Cancer Center), Lu Wang(First Affiliated Hospital Zhejiang University), Yu Chen(Memorial Sloan Kettering Cancer Center), William Lee(Memorial Sloan Kettering Cancer Center), Devan Murphy(Memorial Sloan Kettering Cancer Center), Leili Ran(Memorial Sloan Kettering Cancer Center), Taha Merghoub(Weill Cornell Medicine)
Cited by 251
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
|Immunity|2013|4.7k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k